inebilizumab (Uplizna) Report issue

Biologics mAb Orphan Drug FDA Approved FDA First in Class Breakthrough Therapy FDA
AACT ChEMBL DrugBank
Back

Drug Pricing Summary

VA Big4

$32772.1300

VA FSS

$43666.6633

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
inebilizumab 10 mg / 1 mL (1 mL INJECTION) $32772.1300 VA Big4
  • UPLIZNA (3)
    		•  Viela Bio, Inc.
    inebilizumab 10 mg / 1 mL (1 mL INJECTION) $43666.6633 VA FSS
  • UPLIZNA (3)
    		•  Viela Bio, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue